MedicGo
Perspectives in chemotherapy of schizophrenic psychoses.
Metadata
JournalProg NeuropsychopharmacolNot FoundDate
1979
Type
Review
Journal Article
Volume
1979 / 3 : 39-45
Author
Deniker P 1, Zarifian E
Affiliation

No Data

Doi
PMIDMESH
Acute Disease
Antipsychotic Agents
Brain Chemistry
Chronic Disease
Electroencephalography
Humans
Schizophrenia
Terminology as Topic
Abstract
1. The treatment of schizophrenic symptoms has not the same efficacy in acute and chronic phases of the disease and on the various target symptoms of schizophrenia. 2. The ideal antipsychotic drug might have different properties, sometimes contradictory, to be effective both on paranoid and hebephrenic symptoms which seem to be a mirror image of the same disorder. 3. Basic perspectives in the chemotherapy of schizophrenic psychoses must be founded on better methodological considerations in clinical trials, on a better use of antipsychotic drugs with the help of pharmacokinetic data and computerized EEG and also on new neurochemical findings. 4. Recent data on the mode of action of neuroleptics open up new therapeutic classes of drugs. Such are GABA-like drugs and, more recently, beta-blockers.
Fav
Like
Download
Share
Export
Cite
P
Prog NeuropsychopharmacolProgress in neuro-psychopharmacology
Metadata
Location
From

No Data

© 2017 - 2020 Medicgo
Powered by some medical students